Dentists in Oak Park, CA Accepting Medicare
7 Dentists found. Showing 1 - 7
 Dr. Tad Alan Erickson, D.D.S. Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 346 Kanan Rd, Suite 101, Oak Park, CA 91377 Phone: 818-889-2254 Fax: 818-889-0636 |
Yazdan Alami, DDS Dentist - Pediatric Dentistry Medicare: Not Enrolled in Medicare Practice Location: 368 Kanan Rd, Oak Park, CA 91377 Phone: 818-889-5440 Fax: 818-889-4016 |
 Dr. Maria Cristina Velarde, DMD Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 608 Lindero Canyon Rd, Oak Park, CA 91377 Phone: 818-865-8006 Fax: 818-865-8796 |
Lisa Debs Brennan, DDS Dentist - Pediatric Dentistry Medicare: Not Enrolled in Medicare Practice Location: 368 Kanan Rd, Oak Park, CA 91377 Phone: 818-889-5440 Fax: 818-889-4016 |
Neal Memarian Dentist Medicare: Not Enrolled in Medicare Practice Location: 181 Concerto Dr, Oak Park, CA 91377 Phone: 818-389-9291 |
Dr. Shlomo Steven Frankel, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 368 N Kanan Road, Oak Park, CA 91377 Phone: 818-233-8400 Fax: 747-299-3004 |
Jennifer Ellen Barry, DDS Dentist - Pediatric Dentistry Medicare: Not Enrolled in Medicare Practice Location: 368 Kanan Rd, Oak Park, CA 91377 Phone: 818-889-5440 |
News Archive
Medtronic launch spinal chord stimulation platform for chronic pain management following FDA approval
Medtronic plc announced FDA approval and U.S. launch of the Intellis(TM) platform for the management of certain types of chronic intractable pain. The Intellis platform was designed to overcome limitations with current spinal cord stimulation (SCS) systems, such as battery performance, and can power the EvolveSM workflow*, which standardizes guidance and balances high-dose (HD) and low-dose (LD) therapy settings.
Researchers successfully treat laboratory model of a lysosomal storage disease called GM1
Physicians might one day be able to treat a disease that destroys brain cells in children using genetically modified cells to transport a "drug" to the site of the dying neural cells (cells that transmit impulses).
Researchers reposition existing prazosin drug to combat glioblastoma
Treatments available for glioblastoma—malignant brain tumors—have little effect. An international collaboration led by the Laboratoire Neurosciences Paris-Seine tested active ingredients from existing medications and eventually identified one compound of interest, prazosin, on these tumors. Not only did it seem to be effective in this type of cancer, but it also acted on a signaling pathway that is common with other cancers.
Research report on medical waste management market
MRRBIZ includes new market research report "Medical Waste Management Market (Activity Type - Collection, Processing And Disposal; Waste Generators - Large Quantity Generators And Small Quantity Generators) Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019" to its large collection of research report.
› Verified 8 days ago
Dentists
Pharmacists
Clinical Social Workers
Counselors
Psychologists
Occupational Therapists